Have a feature idea you'd love to see implemented?
Let us know!
CELC Celcuity Inc
Price (delayed)
$14.37
Market cap
$532.1M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$2.73
Enterprise value
$598.15M
Celcuity is a clinical stage biotechnology company translating discoveries of new cancer sub-types into pioneering companion diagnostics and expanded therapeutic options for cancer patients. Celcuity's 3rd generation diagnostic platform, CELsignia,
Highlights
The equity has soared by 60% YoY and by 32% from the previous quarter
The quick ratio has grown by 36% since the previous quarter but it has declined by 30% year-on-year
The debt has soared by 164% YoY and by 154% from the previous quarter
CELC's net income has plunged by 69% YoY and by 12% from the previous quarter
Key stats
What are the main financial stats of CELC
Market
Valuations
Earnings
Shares outstanding
37.03M
Market cap
$532.1M
Enterprise value
$598.15M
Price to earnings (P/E)
N/A
Price to book (P/B)
2.54
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
$0
EBIT
-$76.16M
EBITDA
-$76.03M
Free cash flow
-$66.66M
Per share
Balance sheet
Liquidity
EPS
-$2.73
Free cash flow per share
-$1.73
Book value per share
$5.66
Revenue per share
$0
TBVPS
$7.61
Total assets
$292.54M
Total liabilities
$115.86M
Debt
$96.51M
Equity
$176.68M
Working capital
$272.4M
Debt to equity
0.55
Current ratio
14.95
Quick ratio
14.5
Net debt/EBITDA
-0.87
Margins
Efficiency
Dividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-40.6%
Return on equity
-60.8%
Return on invested capital
-36.2%
Return on capital employed
-27.9%
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
CELC stock price
How has the Celcuity stock price performed over time
Intraday
-5.83%
1 week
-2.04%
1 month
-5.65%
1 year
62.19%
YTD
-1.37%
QTD
-3.62%
Financial performance
How have Celcuity's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$85.4M
Net income
-$82.59M
Gross margin
N/A
Net margin
N/A
The operating income has dropped by 71% year-on-year and by 12% since the previous quarter
CELC's net income has plunged by 69% YoY and by 12% from the previous quarter
Growth
What is Celcuity's growth rate over time
Valuation
What is Celcuity stock price valuation
P/E
N/A
P/B
2.54
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The company's EPS fell by 3% YoY
The equity has soared by 60% YoY and by 32% from the previous quarter
CELC's price to book (P/B) is 31% less than its 5-year quarterly average of 3.9 and 13% less than its last 4 quarters average of 3.1
Efficiency
How efficient is Celcuity business performance
The ROE has decreased by 27% YoY
The return on assets has declined by 16% year-on-year but it has increased by 7% since the previous quarter
Celcuity's return on invested capital has increased by 13% QoQ
Dividends
What is CELC's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for CELC.
Financial health
How did Celcuity financials performed over time
Celcuity's total assets is 152% more than its total liabilities
CELC's total liabilities has surged by 167% year-on-year and by 113% since the previous quarter
Celcuity's total assets has soared by 91% YoY and by 55% from the previous quarter
The debt is 45% less than the equity
The debt has soared by 164% YoY and by 154% from the previous quarter
The company's debt to equity has surged by 96% QoQ and by 67% YoY
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.